Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-09-23

Link:

https://api.zotero.org/groups/2494380/items/7PELS3CQ?format=atom

Updated:

09/23/2020, 09:47

From feeds:

[sandbox] K4D COVID-19 Resource Hub ยป Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

09/23/2020, 10:07

Date published:

09/23/2020, 09:45